After having discussed a possible application with the Expert in Residence, applicants are asked to discuss their potential application with their usual OUI contact. Their OUI contact will be able to help advise them on completing the IP sections of the IP form, and discuss any questions they may have.

LAB282 is managed operationally on behalf of the University and OUI by Dr Richard Reschen, Senior Licensing & Ventures Manager. He is happy to answer any questions relating to the LAB282 scheme from University academics, where they do not have an existing OUI contact.

DR RICHARD RESCHEN

Senior Licensing & Ventures Manager

Richard is a Senior Manager in the Pharma & Biotech team of the Licensing & Ventures group. Here Richard specialises in evaluating, managing and out-licensing patented technology in the Pharma/Biotech sector, and has negotiated numerous complex licensing deals and option agreements with leading companies. He has also raised investment to set up several new spinout companies, and has responsibility for managing the LAB282 initiative.

Richard has a PhD in Cancer Biology from the University of Cambridge, as well as the MPhil in Bioscience Enterprise (with Distinction), an innovative MBA style degree focusing on the pharma/biotech industry.

DR PAUL ASHLEY

Head of Licensing & Ventures, Life Sciences
Oxford University Innovation Ltd.

Paul has an undergraduate degree in Zoology and research experience in neuro-physiology and behaviour. Paul’s PhD and post-doc roles investigated mood disorders and pain.

Moving away from the bench, Paul became the CEO of a spin-out company, commercialising remote monitoring and biotelemetry technology developed at the Defence Science Technology Laboratory. Following this, Paul took up a role at AstraZeneca as a member of the management team at the company’s environmental risk assessment facility.

Paul joined Oxford University Innovation as a Deputy Head of Technology Transfer in July 2011 and has overseen a team of life science Technology Transfer Managers commercialising large numbers of technologies across the breadth of the life sciences, licensing and creating companies in fields including biotech and drug discovery,  medical devices, diagnostics, genomics and digital health.

Lab282 Partners